Delivery Order SPE2DX22D0019-SPE2D825FFA55

Award Date 4/17/25
Potential Completion Date 4/18/25
Potential Value $1.5K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,321.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,838.53 firm fixed-price delivery order contract has an ultimate completion date of April 22, 2025. The contract is not set-aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This federal contract award, valued at $1,247.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 22, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $807,448.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type and has an ultimate completion date of May 15, 2024. The award is not associated with a set-aside program and is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,498,704.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for a firm fixed price with an ultimate completion date of April 15, 2024. The contract is not set aside and allows for the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of various pharmaceutical products and medical supplies to support the U.S. government's medical requirements. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a ceiling value of $1,345.86 and a completion date of August 6, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award, valued at $25,128.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and it does not have a set-aside designation, indicating open competition. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award, valued at $574,193.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price, and no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This federal contract award, valued at $1,976,135.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order classified as Firm Fixed Price, with an ultimate completion date of June 12, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,086,340.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for a firm fixed price and has an ultimate completion date of June 17, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DX22D0019
    Indefinite Delivery Contract
  • SPE2DX22D0019-SPE2D825FFA55
    Delivery Order

This federal contract award, valued at $1,513.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and it has an ultimate completion date of April 18, 2025.

The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This IDC, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. Through this contract, Amerisourcebergen Drug Corp supplies a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and the U.S. Coast Guard.

Generated 7/17/25, 2:24 PM